Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet shares rise as analysts say weight-loss drug fears may be overblown
08:33am, Monday, 02'nd Oct 2023
Insulet Corp. shares PODD, -2.67% gained 4% premarket on Monday after Jefferies analysts upgraded the stock to buy from hold, saying its valuation looks attractive after the shares were dragged down b
Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod® 5
06:00am, Monday, 02'nd Oct 2023
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
06:00am, Thursday, 28'th Sep 2023
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced
Will Insulet (PODD) Stock Recover To Its Pre-Inflation Shock Highs Of $300?
09:00am, Tuesday, 26'th Sep 2023
Returning to the pre-inflation shock level of $318 means that PODD stock will have to gain more than 100% from here.
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.
08:38am, Tuesday, 26'th Sep 2023
Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as ever.
These 20 growth stocks are worth considering on a pullback, says Citi
02:28pm, Monday, 25'th Sep 2023
Citi has released a list of 20 large-cap growth stocks that it says present opportunities in the event of a pullback.
The 7 Most Undervalued Stocks in the Market Right Now: September 2023
05:44pm, Friday, 15'th Sep 2023
With markets remaining choppy and sentiment still cautious, many quality stocks are trading at tempting valuations. Recent indiscriminate selling has knocked down the valuations of profitable, growing
Here's Why You Should Retain Insulet (PODD) Stock for Now
09:46am, Friday, 15'th Sep 2023
Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.
Insulet (PODD) Expands Omnipod 5 Even As Macro Woes Linger
11:20am, Tuesday, 12'th Sep 2023
Insulet's (PODD) international expansion efforts are aligned with its long-term growth profile.
Why Insulet Stock Is Sinking Today
12:34pm, Thursday, 07'th Sep 2023
Insulet's CEO stated today that new diabetes drugs could impact how quickly patients begin insulin therapy. However, the company doesn't expect any long-term impact on sales of its insulin pumps.
Insulet shares slump on concerns of sales hit from new diabetes drugs
10:56am, Thursday, 07'th Sep 2023
Insulin pumps maker Insulet Corp said on Thursday a new generation of diabetes drugs, known as GLP-1s, could delay the time that diabetes patients become dependent on insulin, sending its shares down
The 3 Most Promising Healthcare Stocks to Own Now
06:00pm, Friday, 01'st Sep 2023
The healthcare sector has underperformed this year, with the Health Care Select Sector SPDR (NYSEARCA: XLV ) down 1%. After a disappointing year-to-date performance, it's time to consider some top hea
Why Insulet Stock Rocked the Market Today
06:46pm, Wednesday, 30'th Aug 2023
The medical device specialist's CEO made a large purchase in its stock on Monday. The total outlay for the shares topped $1 million.
Insulet (PODD) Launches Omnipod 5 AID System in Germany
12:46pm, Tuesday, 29'th Aug 2023
Insulet's (PODD) Omnipod 5 is available in the United States and the United Kingdom.
Insulet: Losing More Weight
09:00am, Thursday, 24'th Aug 2023
Insulet Corporation has seen a 30% drop in its shares despite solid Q2 earnings and strong commercial traction. The company aims to simplify the lives of people with diabetes and reduce the burden on
